Register of patients undergoing blood stem cell transplantation
Register of Survey and Evaluation of Blood Stem Cell Transplantations of Clinic III of Internal Medicine III
Technical University of Munich · NCT04263857
This study is tracking patients who have had blood stem cell transplants for blood cancers to see how well they do and what complications they might face.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 5000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Technical University of Munich (other) |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Munich) |
| Trial ID | NCT04263857 on ClinicalTrials.gov |
What this trial studies
This study documents patients who have received autologous or allogenic blood stem cell transplants for hematologic malignancies. It focuses on collecting data regarding complication rates, disease response, survival rates, engraftment, and transplantation settings, including donor and conditioning information. Patients are included during their preparation for transplantation, and their participation is voluntary with the option to withdraw at any time. The study aims to enhance understanding of transplantation outcomes without imposing additional burdens on participants.
Who should consider this trial
Good fit: Ideal candidates for this study are patients who are eligible for blood stem cell transplantation and have provided informed consent.
Not a fit: Patients who are unable to consent to study participation will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve patient outcomes by providing valuable insights into the effectiveness and safety of blood stem cell transplantation.
How similar studies have performed: Other studies have documented outcomes of blood stem cell transplantation, indicating that this approach builds on existing knowledge rather than being entirely novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * signed IC * patients eligible for stem cell transplantation Exclusion Criteria: * unable to consent to study participation
Where this trial is running
Munich
- Klinikum rechts der Isar der TU München — Munich, Germany (RECRUITING)
Study contacts
- Principal investigator: Mareike Verbeek, MD — Klinikum rechts der Isar der TU Munich, Germany
- Study coordinator: Mareike Verbeek, MD
- Email: mareike.verbeek@tum.de
- Phone: +49 89 4140
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Hematologic Malignancies, autologous & allogenic blood stem cell transplantations